quarta-feira, 27 de fevereiro de 2019

Adamis' erectile dysfunction treatment hits regulatory snag as FDA calls marketing application incomplete - Endpoints News

Adamis' erectile dysfunction treatment hits regulatory snag as FDA calls marketing application incomplete - Endpoints News | "marketing" - Google News | February 27, 2019 at 09:48AM
Adamis' erectile dysfunction treatment hits regulatory snag as FDA calls marketing application incomplete  Endpoints News

San Diego-based Adamis has stumbled in its attempt to get a lower-cost erectile dysfunction drug on the market. The specialty pharmaceutical company ...


February 27, 2019 at 09:48AM | "marketing" - Google News
Adamis' erectile dysfunction treatment hits regulatory snag as FDA calls marketing application incomplete - Endpoints News
"marketing" - Google News

Nenhum comentário:

Postar um comentário